News summary

Linearis Labs Selected for Two Projects Under Terry Fox Research Institute

Source: PR Newswire • Published: 16 Sept 2026, 20:00

Summarized by Masters of Longevity from PR Newswire.

Linearis Labs' selection for two funded digital health projects — one on multi-omic AI for cancer and one on AI biomarker work for neurodegeneration — offers a look at collaborative, privacy-preserving research efforts using federated data and advanced analytics.

Linearis Labs Selected for Two Projects Under Terry Fox Research Institute
Key Takeaways
  • Linearis Labs will apply AI to integrated genomic, proteomic, and metabolomic data to predict effective cancer treatments for lung, breast, and colorectal cancers.
  • A second Linearis project uses standardized, secure health data with AI to discover biomarkers and improve monitoring of neurodegenerative diseases.
  • Both projects will use the Digital Health & Discovery Platform's federated learning infrastructure to analyze data across institutions while preserving patient privacy.
Read the full article at PR Newswire

Continue exploring

Recommended MoL Picks

MoL PickCreatine and Cancer: Why New Mouse Studies Point in Opposite DirectionsCreatine strengthened antitumour immune cells in one mouse study—and promoted metastasis through platelets in another. The apparent contradiction reveals why neither result is a supplement recommendation.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.